1 |
Liu, K., Yu, D., Cho, Y. Y., Bode, A. M., Ma, W., Yao, K., Li, S., Li, J., Bowden, G. T., Dong, Z. and Dong, Z. (2013) Sunlight UV-Induced skin cancer relies upon activation of the p38α signaling pathway. Mol. Cell. Biol. 73: 2181-2188.
|
2 |
Sauter, E. R., Nesbit, M., Litwin, S., Klein-Szanto, A. J. P., Cheffetz, S. and Herlyn, M. (1999) Antisense Cyclin D1 induces apoptosis and tumor shrinkage in human squamous carcinomas. Cancer Res. 59: 4876-4881.
|
3 |
Liang, C., Ju, W., Pei, S., Tang, Y. and Xiao, Y. (2017) Pharmacological activities and synthesis of esculetin and its derivatives: a mini-review. Molecules 22: 387.
|
4 |
Choi, Y. J., Lee, C. M. Park, S. H. and Nam, M. J. (2019) Esculetin induces cell cycle arrest and apoptosis in human colon cancer LoVo cells. Environ. Toxicol. 34: 1129-1136.
DOI
|
5 |
Arora, R., Sawney, S., Saini, V., Steffi, C., Tiwari, M. and Saluja, D. (2016) Esculetin induces antiproliferative and apoptotic response in pancreatic cancer cells by directly binding to KEAP1. Mol. Cancer 15: 64.
|
6 |
Turkekul, K., Colpan, R. D., Baykul, T., Ozdemir, M. D. and Erdogan, S. (2018) Esculetin inhibits the survival of human prostate cancer cells by inducing apoptosis and arresting the cell cycle. J. Cancer Prev. 23: 10-17.
DOI
|
7 |
Jeon, Y. J., Jang, J. Y., Shim, J. H., Myung, P. K. and Chae, J. I. (2015) Esculetin, a coumarin derivative, exhibits anti-proliferative and pro-apoptotic activity in G361 human malignant melanoma. J. Cancer Prev. 20: 106-112.
DOI
|
8 |
Yuan, C., Jiang, B., Xu, X., Wan, Y., Wang, L. and Chen, J. (2022) Anti-human ovarian cancer and cytotoxicity effects of nickel nanoparticles green-synthesized by Alhagi maurorum leaf aqueous extract. J. Exp. Nanosci. 17: 113-125.
DOI
|
9 |
Qie, S. and Diehl, J. A. (2016) Cyclin D1, cancer progression, and opportunities in cancer treatment. J. Mol. Med. 94: 1313-1326.
DOI
|
10 |
Eskandari, E. and Eaves, C. J. (2022) Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis. J. Cell Biol. 221: e202201159.
|
11 |
Park, J. E., Kim, D. H., Ha, E. Y., Choi, S. M., Choi, J. S., Chun, K. S. and Joo, S. H. (2019) Thymoquinone induces apoptosis of human epidermoid carcinoma A431 cells through ROS-mediated suppression of STAT3. Chem. Biol. Interact. 312: 108799.
|
12 |
Amini, S., Viera, M. H., Valins, W. and Berman, B. (2010) Nonsurgical innovations in the treatment of nonmelanoma skin cancer. J. Clin. Aesthet. Dermatol. 3: 20-34.
|
13 |
Wang, L., Liu, T., Nishioka, M., Aguirre, R. L., Win, S. S. and Okada, N. (2006) Activation of ERK1/2 and cyclin D1 expression in oral tongue squamous cell carcinomas: Relationship between clinicopathological appearances and cell proliferation. Oral Oncol. 42: 625-631.
DOI
|
14 |
Madan, V., Lear, J. T. and Szeimies, R. M. (2010) Non-melanoma skin cancer. Lancet. 375: 673-685.
DOI
|
15 |
Kohno, M. and Pouyssegur, J. (2006) Targeting the ERK signaling pathway in cancer therapy. Annals of Medicine 38: 200-211.
DOI
|
16 |
Yuan, J., Dong, X., Yap, J. and Hu, J. (2020) The MAPK and AMPK signalings: interplay and implication in targeted cancer therapy. J. Hematol. Oncol. 13: 1-19.
DOI
|
17 |
Li, J., Malakhova, M., Mottamal, M., Reddy, K., Igor, K., Andria, C., Langfald, A., Oi, N., Kim, M. O., Zhu, F., Sosa, C. P., Zhou, K., Bode, A. N. and Dong, Z. (2012) Norathyriol suppresses solar UV-induced skin cancer by targeting ERKs. Cancer Res. 72: 260-270.
|
18 |
Chambard, J. C., Lefloch, R., Pouyssegur, J. and Lenormand, P. (2007) ERK implication in cell cycle regulation. Biochim. Biophys. Acta - Mol. Cell Res. 1773: 1299-1310.
DOI
|
19 |
Zhang, J. and Bowden, G. T. (2012) Activation of p38 MAP kinase and JNK pathways by UVA irradiation. Photochem. Photobiol. Sci. 11: 54-61.
DOI
|
20 |
Hammouda, M. B., Ford, A. E., Liu, Y. and Zhang, J. Y. (2020) The JNK signaling pathway in inflammatory skin disorders and cancer. Cells 9: 857.
|
21 |
Bachelor, M. A. and Bowden, G. T. (2004) Ultraviolet A-induced modulation of Bcl-XL by p38 MAPK in human keratinocytes. Biol. Chem. 279: 42658-42668.
DOI
|